
Stem Cell Cure Private Limited
About Stem Cell Cure Private Limited
Data last updated:
Stem Cell Cure Private Limited is a private limited company based in Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 30 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2011PTC224348. Its GSTIN is 07AAQCS2431L1Z0 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tanu and Prashant Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No – 103 Old No – 22 Laxmi Nagar Waliya Nursing Hom, E Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.33 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Lakh (net margin 0.8%) and EBITDA of ₹1.5 Lakh (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years and 34% over five years.
The company is associated with 1 brand: Stem Cell Therapy India. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Stem Cell Cure Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo – 103 Old No – 22 Laxmi Nagar Waliya Nursing Hom, E Delhi, Delhi, India – 110092
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Stem Cell Cure Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stem Cell Cure operates one associated brand: Stem Cell Therapy India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers stem cell treatments for degenerative diseases and medical tourism in India. | stemcellcure.in |
Business activity
The main business activity of Stem Cell Cure is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Stem Cell Cure Private Limited, buy the company report.
Financials of Stem Cell Cure Private Limited
FY 2025 filings availableStem Cell Cure Private Limited reported revenue of ₹1.33 Cr (up 42% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 42% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stem Cell Cure Private Limited, buy the company report.
Board of directors of Stem Cell Cure Private Limited
Stem Cell Cure has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tanu Also directs: Rade Construction Private Limited, Stem Cell Cure India Private Limited, Be Donor Online Ventures Private Limited and 2 more | Director | 01 Jun 2018 | 8 Years 5 Months | Current |
| Prashant Tyagi Also directs: Rade Construction Private Limited, NCL Foods Private Limited, Nany Calibration Laboratory Private Limited and 3 more | Director | 30 Aug 2011 | 15 Years 2 Months | Current |
Auditor
Stem Cell Cure Private Limited is audited by AWADHESH ANURAG JAI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AWADHESH ANURAG JAI & ASSOCIATES | FY 2017 | 011512C |
Shareholding
The shareholding of Stem Cell Cure Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Stem Cell Cure Private Limited, buy the company report.
Legal cases
Stem Cell Cure Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Stem Cell Cure Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stem Cell Cure Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stem Cell Cure has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCS2431L1Z0 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stem Cell Cure Private Limited, buy the company report.
Recent activity
Stem Cell Cure Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Tanu ceased to be Additional Director on 10 Mar 2019.
Frequently asked questions
Stem Cell Cure is an active private limited company based in Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 30 August 2011 (15+ years old) and is registered under CIN U85100DL2011PTC224348.
Stem Cell Cure has 2 current directors:
- Tanu - Director
- Prashant Tyagi - Director
The latest financial statements of Stem Cell Cure on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stem Cell Cure is 07AAQCS2431L1Z0, registered in Delhi.
The CIN (Corporate Identification Number) of Stem Cell Cure is U85100DL2011PTC224348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stem Cell Cure has 1 court case on record: 1 filed against it.
Stem Cell Cure was incorporated on 30 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Tanu ceased to be Additional Director on 10 Mar 2019. Nishant Tyagi ceased to be Director on 01 Jun 2018. Tanu was appointed as Director on 01 Jun 2018. Stem Cell Cure has 4 board changes on record in total.
The registered office of Stem Cell Cure is at No – 103 Old No – 22 Laxmi Nagar Waliya Nursing Hom, E Delhi, Delhi, India – 110092.
Stem Cell Cure operates in the healthcare industry, in the preventive health services segment.

